| Blood product replacement for postpartum hemorrhage. | |
| | |
MedLine Citation:
|
PMID: 20142656 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hemorrhage requiring blood transfusion is a common occurrence in obstetrics. This article reviews each step in the transfusion process, including laboratory preparation of blood, indications for various blood components, complications of blood transfusion, massive transfusion, and alternatives to homologous blood. Current thinking regarding transfusion-related acute lung injury, transfusion-related immunomodulation, early use of plasma for massive transfusion, and the use of adjuvant agents such as activated recombinant factor VII are also discussed. |
| | |
Authors:
|
Andrea J Fuller; Brenda A Bucklin |
Related Documents
:
|
716626 - Blood transfusion--a review of the literature. 1777446 - Rapid in-line blood warming using microwave energy: preliminary studies. 7269456 - Effect of age and 2,3-dpg content of transfused blood on serum erythropoietin. 7370146 - Fine screen filtration of banked blood: effect on red cell survival. 1533006 - Measurement of blood flow from an assist ventricle by computation of pneumatic driving ... 19552696 - Duffy antigen expression on reticulocytes does not alter following blood loss in an aut... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical obstetrics and gynecology Volume: 53 ISSN: 1532-5520 ISO Abbreviation: Clin Obstet Gynecol Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-02-09 Completed Date: 2010-05-12 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0070014 Medline TA: Clin Obstet Gynecol Country: United States |
Other Details:
|
Languages: eng Pagination: 196-208 Citation Subset: IM |
Affiliation:
|
Department of Anesthesiology, University of Colorado at Denver Health Sciences Center, Aurora, Colorado, USA. Fuller@ucdenver.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Transfusion
/
adverse effects,
methods* Factor VIIa / therapeutic use Female Humans Postpartum Hemorrhage / diagnosis, therapy* Pregnancy Recombinant Proteins / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Recombinant Proteins; 0/recombinant FVIIa; EC 3.4.21.21/Factor VIIa |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Surgical remedies for postpartum hemorrhage.
Next Document: Endovascular treatment of postpartum hemorrhage.